SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 28 filers reported holding SCPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,150 | -17.4% | 16,594 | +18.3% | 0.00% | – |
| Q2 2023 | $142,955 | +376.5% | 14,029 | +212.1% | 0.00% | – |
| Q1 2021 | $30,000 | +15.4% | 4,495 | -8.7% | 0.00% | – |
| Q4 2020 | $26,000 | 0.0% | 4,924 | +40.4% | 0.00% | – |
| Q3 2020 | $26,000 | +44.4% | 3,508 | +41.8% | 0.00% | – |
| Q2 2020 | $18,000 | 0.0% | 2,474 | -23.1% | 0.00% | – |
| Q4 2019 | $18,000 | +260.0% | 3,217 | +75.8% | 0.00% | – |
| Q2 2019 | $5,000 | -80.0% | 1,830 | -78.5% | 0.00% | – |
| Q1 2019 | $25,000 | -24.2% | 8,504 | -5.4% | 0.00% | – |
| Q4 2018 | $33,000 | -80.8% | 8,993 | -69.6% | 0.00% | – |
| Q3 2018 | $172,000 | +20.3% | 29,568 | +15.7% | 0.00% | – |
| Q2 2018 | $143,000 | +22.2% | 25,550 | +170.1% | 0.00% | – |
| Q1 2018 | $117,000 | – | 9,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $23,410,000 | 5.89% |
| AIGH Capital Management LLC | 642,154 | $3,924,000 | 0.71% |
| Ikarian Capital, LLC | 1,095,024 | $6,690,000 | 0.54% |
| Worth Venture Partners, LLC | 163,994 | $1,002,000 | 0.37% |
| Orbimed Advisors | 4,797,148 | $29,311,000 | 0.30% |
| RA Capital Management | 2,731,170 | $16,687,000 | 0.27% |
| J. Goldman & Co LP | 720,877 | $4,405,000 | 0.17% |
| DAFNA Capital Management LLC | 38,891 | $238,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124,827 | $763,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,200 | $624,000 | 0.01% |